Pharmacology of ayahuasca administered in two repeated doses
The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Abstract
Rationale Ayahuasca is an Amazonian tea containing the natural psychedelic 5-HT(2A/2C/1A) agonist N,N-dimethyltryptamine (DMT). It is used in ceremonial contexts for its visionary properties. The human pharmacology of ayahuasca has been well characterized following its administration in single doses. Objectives To evaluate the human pharmacology of ayahuasca in repeated doses and assess the potential occurrence of acute tolerance or sensitization. Methods In a double-blind, crossover, placebo-controlled clinical trial, nine experienced psychedelic drug users received PO the two following treatment combinations at least 1 week apart: (a) a lactose placebo and then, 4 h later, an ayahuasca dose; and (b) two ayahuasca doses 4 h apart. All ayahuasca doses were freeze-dried Amazonian-sourced tea encapsulated to a standardized 0.75 mg DMT/kg bodyweight. Subjective, neurophysiological, cardiovascular, autonomic, neuroendocrine, and cell immunity measures were obtained before and at regular time intervals until 12 h after first dose administration. Results DMT plasma concentrations, scores in subjective and neurophysiological variables, and serum prolactin and cortisol were significantly higher after two consecutive doses. When effects were standardized by plasma DMT concentrations, no differences were observed for subjective, neurophysiological, autonomic, or immunological effects. However, we observed a trend to reduced systolic blood pressure and heart rate, and a significant decr…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ayahuasca has been demonstrated to be safe in naturalistic (35, 108) and clinical settings, across varying dosages and multiple administrations (26, 109–112).”
From Ayahuasca-assisted meaning reconstruction therapy for grief: a non-randomized clinical trial protocol (2025) · cites this paper as [111]
In the citing paper
“Besides actions on the vegetative nervous system ayahuasca also induces endocrine response. Elevation in prolactin, cortisone, and growth hormone levels has been reported (dos Santos et al., 2011; dos Santos et al., 2012).”
From The therapeutic potentials of Ayahuasca: possible effects against various diseases of civilization (2016) · cites this paper as dos Santos et al., 2012
In the citing paper
“Ayahuasca also influences the distribution of lymphocyte subpopulation: CD4 lymphocytes decrease and the number of natural killer cells increase significantly with time (dos Santos et al., 2012).”
From The therapeutic potentials of Ayahuasca: possible effects against various diseases of civilization (2016) · cites this paper as dos Santos et al., 2012
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Martin, W. R., Sloan, J. W., Sapira, J. D., & Jasinski, D. R. (1971) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1971122part1245 · Cited by 943
Strassman, R. J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950020022002 · Cited by 453 · cited 2×
“…interact with his/her " self " and/or the environment; Cognition, describing modifications in thought processes or content; Perception, measuring visual, auditory, gustatory, and olfactory experiences; and Intensity, reflecting the strength of the overall experience (Strassman et al. 1994).”
BackgroundMcKenna, D. J., Towers, G. H. N., & Abbott, F. (1984) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(84)90003-5 · Cited by 398
Riba, J., Valle, M., Urbano, G., Yritia, M., Morte, A., & Barbanoj, M. J. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.049882 · Cited by 390 · cited 3×
“…cognitive, and affective modifications typical of the psychedelics, plus physiological effects that include elevations in diastolic blood pressure, cortisol and prolactin and lymphocyte redistribution, and electroencephalographic changes (Riba et al. 2002; 2003; Santos et al., in press).”
BackgroundMethodInfluentialSelf-citationPharmacokinetics of Hoasca alkaloids in healthy humans
Callaway, J. C., McKenna, D. J., Grob, C. S., Brito, G. S., Raymon, L. P., Poland, R. E., Andrade, E. N., Andrade, E. O., & Mash, D. C. (1999) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(98)00168-8 · Cited by 315
Williams, C. H. (1974) · Biochemical Pharmacology · doi:10.1016/0006-2952(74)90626-1 · Cited by 314
Riba, J., Rodríguez-Fornells, A., Urbano, G., Morte, A., Antonijoan, R., Montero, M., Callaway, J. C., & Barbanoj, M. J. (2001) · Psychopharmacology · doi:10.1007/s002130000606 · Cited by 303 · cited 7×
“Vomiting is commonly reported for liquid ayahuasca but rarely observed after single dose administration of the encapsulated freeze-dried formulation (Riba et al. 2001a; Riba et al. 2003).”
BackgroundMethodResultInfluentialSelf-citationStrassman, R. J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950020009001 · Cited by 291 · cited 3×
“In contrast, Strassman and Qualls (1994) found increases in rectal temperature for intravenous DMT administered at doses of 0.2–0.4 mg/kg, an effect that was also observed previously for ayahuasca (Callaway et al. 1999) and for serotonergic compounds such as the mixed 5-HT agonist…”
BackgroundInfluentialThe globalization of ayahuasca: harm reduction or benefit maximization?
Tupper, K. W. (2008) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2006.11.001 · Cited by 212 · cited 2×
“Ayahuasca is a psychoactive tea that was originally used for its visionary properties in shamanic, religious, and medicinal contexts in the Amazon but is now used worldwide in ceremonial and lay contexts (Tupper 2008).”
Background
Research works printed but not linked: 1
- First MB, Spitzer RL, Gibbon M, Williams JB (1999) Entrevista Clínica Estructurada para los Trastornos del Eje I del DSM-IV: Versión Clínica (SCID-VC). Masson, Barcelona
Cited by
Osório, F. D. L., Sanches, R. F., Macedo, L. R., dos Santos, R. G., Maia-de-Oliveira, J. P., Wichert-Ana, L., de Araujo, D. B., Riba, J., Crippa, J. A., & Hallak, J. E. (2015) · Revista Brasileira de Psiquiatria · doi:10.1590/1516-4446-2014-1496 · Cited by 488
Palhano-Fontes, F., Andrade, K. C., Tofoli, L. F., Santos, A. C., Crippa, J. A. S., Hallak, J. E. C., Ribeiro, S., & de Araujo, D. B. (2015) · PLOS ONE · doi:10.1371/journal.pone.0118143 · Cited by 454
“In order to gain insight into the neurophysiology underlying mental imagery induced by psychedelics, we have used functional Magnetic Resonance Imaging (fMRI) to investigate the effects of Ayahuasca, a powerful psychedelic traditionally used by Amazonian Amerindians, and then spread to Western countries, occupying the…”
MethodAdverse effects of psychedelics: From anecdotes and misinformation to systematic science
Schlag, A. K., Aday, J., Salam, I., Neill, J. C., & Nutt, D. J. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811211069100 · Cited by 325
“The fast build-up of tolerance and lack of withdrawal symptoms has been repeatedly shown in the literature (e.g. Krebs and Johansen, 2013; Liechti, 2017; Nichols, 2004), except for ayahuasca, which leads to minimal tolerance (Dos Santos et al., 2012).”
BackgroundResultInfluentialBouso, J. C., González, D., Fondevila, S., Cutchet, M., Fernández, X., Ribeiro Barbosa, P. C., Alcázar-Córcoles, M. Á., Araújo, W. S., Barbanoj, M. J., Fábregas, J. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042421 · Cited by 313
“Physiological modifications include moderate increases in blood pressure, elevations of blood cortisol and prolactine and lymphocyte redistribution [10,11,12,14].”
BackgroundSelf-citationdos Santos, R. G., Osório, F. L., Crippa, J. A. S., Riba, J., Zuardi, A. W., & Hallak, J. E. C. (2016) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125316638008 · Cited by 306
Metadata
- Authors
- dos Santos, R. G., Grasa, E., Valle, M., Ballester, M. R., Bouso, J. C., Nomdedéu, J. F., Homs, R., Barbanoj, M. J., & Riba, J.
- Affiliations
- Centro de Investigación Biomédica en Red de Salud Mental (ES)
- Universitat Autònoma de Barcelona (ES)
- Hospital de Sant Pau (ES)
- Venue
- Psychopharmacology
- Published
- 2011-08-13
- Volume
- 219
- Issue
- 4
- Pages
- 1039-1053
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2062339243
- Cited by
- 141
- References
- 44
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 16 · 2023: 12 · 2022: 19 · 2021: 13 · 2020: 10 · 2019: 3 · 2018: 7 · 2017: 6 · 2016: 12 · 2015: 9 · 2014: 4 · 2013: 7 · 2012: 6
- FWCI
- 5.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Alkaloids: synthesis and pharmacology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- ayahuasca, N,N-dimethyltryptamine, repeated dosing, acute tolerance, sensitization, prolactin, cortisol, growth hormone, cardiovascular effects, autonomic nervous system, neuroendocrine response, immune response, subjective effects
- MeSH terms
- Adult, Blood Pressure, N,N-Dimethyltryptamine, Double-Blind Method, Drug Administration Schedule, Drug Tolerance, Hallucinogens, Heart Rate, Humans, Male, Plant Extracts, Growth Hormone, Tea, Time Factors, Cross-Over Studies, Banisteriopsis, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacology of ayahuasca administered in two repeated doses. https://app.cochat.ai/papers/10.1007/s00213-011-2434-x
- The paper
- dos Santos, R. G., Grasa, E., Valle, M., Ballester, M. R., Bouso, J. C., Nomdedéu, J. F., Homs, R., Barbanoj, M. J., & Riba, J. (2012). Pharmacology of ayahuasca administered in two repeated doses. Psychopharmacology. https://doi.org/10.1007/s00213-011-2434-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.